🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is: * To assess the effect of BIA 5 1058 400 mg ...
Status
Completed
Location
Simbec Research Ltd (Simbec)
Start Date
2018-06-11
Trial ID
NCT07173738
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested
Primary Objective: To demonstrate the vaccine seroresponse sufficiency of ...
Status
Completed
Location
Investigational Site Number 8400012
Start Date
2019-09-03
Trial ID
NCT04084769
Substudy A: The study aims to learn about the safety and effects of two new...
Status
Completed
Location
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Start Date
2023-03-09
Trial ID
NCT05788237
CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Status
Completed
Location
University Southern California
Start Date
2008-10-20
Trial ID
NCT00925756
Treatments Being Tested
Primary Objective: To evaluate the overall response rate (including comple...
Status
Completed
Location
Multiple Locations
Start Date
2014-05
Trial ID
NCT02061631
Treatments Being Tested
The study aims to evaluate the effect of fluconazole on the pharmacokinetic...
Status
Completed
Location
Anaheim Clinical Trials
Start Date
2014-11
Trial ID
NCT02325011
Treatments Being Tested
To evaluate if safinamide at the steady state, obtained after multiple 100 ...
Status
Completed
Location
CROSS Research SA, Phase I Unit
Start Date
2017-05-22
Trial ID
NCT03216304
Treatments Being Tested
This study consisted of 2 parts: a double-blind (DB) phase and an open-labe...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-11
Trial ID
NCT02564952
Treatments Being Tested